Trial intelligence / Profile preview

Low Dose Magnesium Sulphate in Nasal Surgery

NCT06621004Phase 1Enrolling by invitation

Sponsor
Ain Shams University
Start
Aug 2024
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of magnesium sulfate in sinusitis (2 arms), sponsored by Ain Shams University. Primary endpoint: Mean Arterial Blood Pressure. Started Aug 2024; status: enrolling by invitation.

02

Drugs

magnesium sulfate
03

Conditions

sinusitis

Beyond the preview

Go deeper on NCT06621004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06621004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call